Anxiety & Stress
The relationship between cannabis and anxiety is nuanced. CBD has demonstrated clear anxiolytic properties in clinical research, while THC's effect on anxiety is dose-dependent — small doses reduce anxiety while larger doses can cause it.
Quick Reference
CBD as an Anxiolytic
Cannabidiol (CBD) has been the subject of substantial anxiety research. A 2019 study found that 79% of patients reported decreased anxiety scores within the first month of CBD treatment. Multiple animal studies and several human trials demonstrate CBD's anxiolytic effects across generalised anxiety disorder (GAD), social anxiety disorder (SAD), PTSD, and panic disorder. Notably, a landmark 2011 double-blind study found CBD significantly reduced anxiety, cognitive impairment and discomfort in participants with social anxiety disorder during a simulated public speaking test.
THC and Anxiety — The Dose Paradox
THC has a complex, dose-dependent relationship with anxiety. At low doses (2.5–7.5mg), THC has demonstrated anxiolytic and mood-elevating effects. At higher doses (12.5mg+), THC reliably produces anxiety and even paranoia in a significant proportion of users. This is why many medical practitioners prescribe CBD-dominant preparations for anxiety, or very low-dose THC with monitoring. The ratio of CBD to THC is also important — CBD modulates THC's anxiety-inducing effects, making balanced preparations less likely to cause anxiety than pure THC.
PTSD and Cannabis
Post-traumatic stress disorder (PTSD) has become one of the strongest indications for medical cannabis in jurisdictions where it is approved. The endocannabinoid system plays a key role in fear memory consolidation and extinction — the processes disrupted in PTSD. Several clinical trials have shown cannabis reduces PTSD symptom severity, nightmares, hyperarousal and insomnia in veterans and trauma survivors. Canada, several US states, Germany and Israel all include PTSD as a qualifying condition for medical cannabis programmes.
Social Anxiety Disorder
Social anxiety disorder (SAD) is the most studied anxiety condition in cannabis research. CBD has shown particular promise here. In a simulated public speaking paradigm, participants pre-treated with CBD showed significantly reduced anxiety compared to placebo, with performance comparable to non-anxious controls. This finding has been replicated in multiple studies. CBD does not produce sedation or cognitive impairment at anxiolytic doses, making it suitable for daytime use in social situations.
Practical Guidance for Anxiety
For anxiety management, CBD-dominant or pure CBD preparations are the preferred starting point. Begin with 15–25mg oral CBD daily, taken consistently rather than as-needed for best results. If adding THC, start at 2.5mg or below and only increase slowly with careful monitoring of anxiety response. Avoid high-THC strains and concentrates entirely if anxiety is your primary concern. Micro-dosing — consuming very small quantities multiple times per day — has become popular for anxiety management as it maintains consistent cannabinoid levels while minimising psychoactive effects.
When Cannabis May Worsen Anxiety
Cannabis can worsen anxiety in a significant minority of users, particularly those with: a personal or family history of psychosis or schizophrenia, panic disorder, existing high baseline anxiety, high sensitivity to THC, or those consuming high-THC products. Young people under 25 are at significantly higher risk of cannabis-induced anxiety and psychosis. If cannabis worsens your anxiety, discontinue use and consult your healthcare provider. Cannabis is not appropriate for everyone with anxiety.